What is Bayshore Ophthalmology?
Based in Holmdel, New Jersey, Bayshore Ophthalmology operates as a high-acuity clinical practice dedicated to comprehensive vision health. Under the leadership of board-certified specialist Dr. Surekha Collur, the organization delivers a sophisticated suite of medical interventions, ranging from complex cataract surgeries and glaucoma management to precision laser vision correction. The clinic distinguishes itself through a patient-centric model that integrates pediatric ophthalmology with specialized diabetic eye care, supported by an on-site optical center. This multi-disciplinary approach ensures that the practice remains a critical node in the regional healthcare infrastructure, effectively bridging the gap between routine vision maintenance and advanced surgical intervention.
How much funding has Bayshore Ophthalmology raised?
Bayshore Ophthalmology has raised a total of $333K across 2 funding rounds:
Debt
$150K
Debt
$183K
Debt (2020): $150K with participation from PPP
Debt (2021): $183K led by PPP
Key Investors in Bayshore Ophthalmology
PPP
Public-Private Partnership
What's next for Bayshore Ophthalmology?
With the recent infusion of capital, Bayshore Ophthalmology is well-positioned to scale its clinical infrastructure and enhance its technological capabilities. The strategic deployment of these funds will likely focus on the acquisition of next-generation diagnostic equipment and the expansion of surgical throughput to meet rising regional demand. As the practice navigates its current growth phase, the focus remains on maintaining high-quality patient outcomes while optimizing operational efficiencies. Future initiatives may include the integration of digital health platforms to streamline patient management and the potential expansion of specialized service lines to address the evolving needs of the aging demographic in the tri-state area.
See full Bayshore Ophthalmology company page
